The results of the study that the "aspirin use," or similar drugs can
double the risk of colorectal cancer among persons with certain genetic
variants, despite many previous research showed that these drugs can
reduce this risk by 30 percent
A new step on the road to modern therapy seeks to agree precisely with the genetic makeup of the patients went and represents an outcome which was published yesterday (Tuesday).
If confirmed, this result may have changed for the prevention of tumors of colorectal statistics which indicate that they would kill 49 thousand and 700 people in the United States this year recommendations.
In an article published in addition to research in the journal "American Medical Association" Richard Wonder of "the American Society of Clinical Oncology," and Thomas Jefferson University, these results as "the great importance of medical terms."
He said, "I am particularly excited while monitoring becomes genome sequence to prevent a lifetime of colorectal cancer."
Doctors prescribe the "aspirin" and other anti-inflammatory drugs is Asteroidah for patients who suffer from polyps in the colon, but it is for most people, they do not recommend this, because the use of such drugs on a regular basis may cause bleeding stomach and intestines.
And ensure that the research funded by "the US National Institutes of Health" significantly, collecting ten results of studies based on the viewing involving 17 thousand and 187 people in the United States, Canada, Australia and Germany.
Coupled with the regular use of "aspirin" and drugs like it, such as "ibuprofen" the emergence of 17 cases of colon and rectum cancer among every 100 thousand people.
But the results were quite different for people with a genetic changes in DNA (the DNA), as it appeared about 35 cases of colorectal tumors among every 100 thousand people have a genetic variant.
And no such variables by between four to nine percent of the people who come from European descent.
0 التعليقات:
إرسال تعليق